Regeneron Pharmaceuticals Inc (NASDAQ:REGN) - Overview

Stock Report

Regeneron Pharmaceuticals Inc REGN

Last Price
$372.71

Day Change
-2.85|-0.76%

As of 02/12/2016
16:00:01 EST | USD
Minimum 15 Minutes Delay.

Last Close375.56
Day Range371.32 - 378.50
Mkt Cap39.31Bil
52-Wk Range325.35 - 563.79
Yield %-
ISINUS75886F1075
Volume723,571
P/E54.41
P/S9.16
P/CF31.47

Share Price

Financials
201320142015
More ...
Income Statement
Revenue2,104.752,819.564,103.73
Operating Income760.03838.431,251.92
Net Income424.36348.07636.06
Basic EPS4.333.466.17
Avg. Diluted Shares Outstanding111113115
Balance Sheet
Current Assets1,796.932,167.462,915.10
Non Current Assets1,154.081,704.372,694.04
Total Assets2,951.013,871.835,609.13
Current Liabilities298.84654.66811.16
Total Liabilities998.941,329.501,954.30
Total Equity1,952.082,542.333,654.84
Cash Flow
Operating Cash Flow583.65743.161,330.78
Capital Expenditure-156.32-333.01-677.93
Free Cash Flow427.33410.15652.85

In millions, except "Basic EPS". Currency is USD.

Company Profile

Regeneron Pharmaceuticals Inc is a fully integrated biopharmaceutical company. It discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Large-Growth

Fiscal Year Ends

December

Employees

4,300
Key Stats
More ...
Price/Earning TTM49.22
Price/Book8.82
Price/Sales TTM9.38
Rev Growth (3 year avg)43.86
EPS Growth (3 year avg)-
Operating Margin % TTM30.51
Net Margin % TTM15.50
ROE TTM20.53
Debt/Equity0.10
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2016 Morningstar. All rights reserved.